The current vaccines are expected to supply protection towards COVID-19 caused by the now circulating variants. Barring the emergence of a markedly additional infectious variant of SARS-CoV-2, the FDA anticipates that the composition of COVID-19 vaccines will should be assessed annually, as happens for seasonal influenza vaccines. Charming web-sit